Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Conditions: Lung Cancer, Non-squamous, Non-small Cell Interventions: Drug: zongertinib; Drug: pembrolizumab; Drug: cisplatin; Drug: carboplatin; Drug: pemetrexed Sponsors: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Cancer | Cancer & Oncology | HER2 | Lung Cancer | Non-Small Cell Lung Cancer | Research | Study